1REGN:BIT
Regeneron Pharmaceuticals Inc
€659.80
arrow_upward
+1.15%(+7.50) 1D
Oct 2, 5:26:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
MarketBeat
·
35 minutes ago
Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by BDF Gestion
Yahoo Finance
·
53 minutes ago
Strong Dupixent Trajectory Anchors Regeneron Pharmaceuticals’ (REGN) Solid Financial Results
Trefis
·
1 hour ago
How Much Upside Is Left In Regeneron Stock?
The Motley Fool
·
2 hours ago
Forget Eli Lilly and Novo: This Biotech Could Be a Surprising Winner in the Weight Loss Market
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia